Review Article
Multidrug Resistance in Breast Cancer: From In Vitro Models to Clinical Studies
Table 3
Effect of ABC transporters on patient response rate to chemotherapy.
| | All chemotherapy | Cyclophosphamide. Methotrexate and 5-Fluorouracil | 5-Fluorouracil, epirubicin/doxorubicin and cyclophospamide |
| All patients | 34/59 (58%) | 15/28 (54%) | 19/31 (61%) | Low BCRP | 27/42 (64%) | 11/20 (55%) | 16/22 (73%) | High BCRP | 7/17 (41%) | 4/8 (50%) | 3/9 (33%) | Low MRP1 | 18/30 (60%) | 8/16 (50%) | 10/14 (71%) | High MRP1 | 16/29 (55%) | 7/12 (58%) | 9/17 (53%) | Low MRP2 | 18/28 (64%) | 5/8 (63%) | 13/20 (65%) | High MRP2 | 13/28 (46%) | 8/18 (44%) | 5/10 (50%) | Low PGP | 32/47 (68%) | 13/22 (59%) | 19/25 (76%) | High PGP | 2/12 (17%) | 2/6 (33%) | 0/6 (0%) |
|
|